These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 474324)

  • 1. Complement in hematological neoplasias.
    Batlle Fonrodona FJ; López Fernández MF; Vicente García V; Corral Alonso M; López Borrasca A
    Allergol Immunopathol (Madr); 1979; 7(1):39-46. PubMed ID: 474324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.
    Lichtenfeld JL; Wiernik PH; Mardiney MR; Zarco RM
    Cancer Res; 1976 Oct; 36(10):3678-80. PubMed ID: 953991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
    Hashimi L; Wang CY; Al-Katib A; Koziner B
    Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
    Harris NL
    Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
    Jaffe ES; Zarate-Osorno A; Medeiros LJ
    Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complement. Evaluation of some complement fractions in patients affected by neoplasia undergoing chemotherapy (author's transl)].
    Ignesti C; Lenzi L; Salvadori D; Innocenti V; Baroncelli C; Casadei BM
    Quad Sclavo Diagn; 1981 Jun; 17(2):152-6. PubMed ID: 6943601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial occurrence of malignant hematologic diseases].
    Chrz M; Benesová E; Ceslar P; Trnĕný M
    Cas Lek Cesk; 1992 Jun; 131(14):437-42. PubMed ID: 1369814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in patients with lymphomas and leukemias.
    Patel GV; Gopal R; Nadkarni JJ
    Neoplasma; 1984; 31(2):197-202. PubMed ID: 6585680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia].
    Beretta KR; Späth PJ; Pedrazzini A; Martinelli G; Cavalli F
    Schweiz Med Wochenschr; 1991 Jun; 121(25):943-7. PubMed ID: 1862309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The single cell gel electrophoresis: a potential tool for DNA analysis of the patients with hematological malignancies.
    Bacová G; Gábelová A; Babusíková O; Slamenová D
    Neoplasma; 1998; 45(6):349-59. PubMed ID: 10210107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.